Full Name
Brittany N. Lasseigne
Job Title
Assistant Professor, Department of Cell, Development and Integrative Biology
Company or Organization
The University of Alabama at Birmingham School of Medicine
Speaker Bio
Dr. Brittany Lasseigne completed a BS in Biological Engineering at Mississippi State University, an interdisciplinary biology, chemistry, and chemical engineering PhD in Biotechnology Science and Engineering from The University of Alabama in Huntsville, and a postdoctoral fellowship in genetics and genomics at the HudsonAlpha Institute for Biotechnology. Her prior research accomplishments include studying the role of DNA methylation and copy number variation in cancer, discovery of gene variants linked to ALS, and characterization of gene expression patterns in psychiatric disorders.

The Lasseigne Lab uses genomic strategies and data to study both common and rare diseases with the goal of discovering biological signatures that might be used to improve patient care and provide insight into molecular processes contributing to disease. By integrating genomic data, functional annotations, and patient information with machine learning they aim to identify genome-driven therapeutic targets and biomarkers by liquid biopsy and understand how context dependency contributes to complex diseases.

Dr. Lasseigne has received several honors for her academic work including the National Merit and Hosmer Engineering Excellence Awards, Prevent Cancer Foundation’s William J. Maier III Fellowship in Cancer Prevention, and an NIH NHGRI K99/R00 Pathway to Independence Award. She is passionate about science education and outreach, previously served as founding faculty advisor for the International Society for Computational Biology Regional Student Group Southeast, teaches foundational coding and data science skills nationally as a Software and Data Carpentry Instructor, and is a member of the Software Carpentry Curriculum Advisory Committee.

Dr. Lasseigne is currently an Assistant Professor in the Department of Cell, Developmental and Integrative Biology, an Associate Scientist in the O’Neal Comprehensive Cancer Center Experimental Therapeutics Program and the Center for Clinical and Translational Scientist, and a Scientist in both the Informatics Institute and the Hugh Kaul Precision Medicine Institute at the University of Alabama at Birmingham.
Brittany N. Lasseigne